|Last Price$63.57||Day Change (%)0.46%|
|Open Price$63.39||Day Change ($)0.29|
|Day Range63.14–63.67||52-Week Range51.79–71.90|
As of Thu 09/18/2014 01:30 PM EST | USD
Twelve-Month Data from St . Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients
Large-scale Study Confirms Growing Body of Clinical Evidence for the St . Jude Medical Quadripolar System
New Clinical Trial Results Demonstrate Importance of St . Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients
St . Jude Medical to Present at the Morgan Stanley Global Healthcare Conference
Research and Markets: Cardiac Pacemaker Market in India 2014
Research and Markets: Global Heart Defect Closure Devices Market Report 2014-2018 - Boston Scientific, St . Jude Medical & W.L. Gore and Associates Dominates
GI Dynamics, Inc. Announces the Appointment of Medical Device Industry Veteran Michael D. Dale as President & Chief Executive Officer
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Widening investment-grade credit spreads and rising interest rates lead to losses.
Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.